Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A patient-driven clinicogenomic partnership for metastatic prostate cancer

Cell Genomics(2022)10.1016/j.xgen.2022.100169Source: DataRank Database

A patient-driven clinicogenomic partnership for metastatic prostate cancer is a research paper published in Cell Genomics (2022). On theSindex it has a DataRank of 0.460. It has been cited 10 times, with 9 citing works in its 1-hop citation network.

N/A

0.460DataRank · unranked

Scored on demand from live citation data

Open Access10 citations · 9 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 0.97)OA: goldTopics (20)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 78%Citation Network 22%

Base Score Contribution

0.360

From this paper's citation signal

Citation Network Contribution

0.0999

From 6 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 9 citers.

Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
Oncogenesis20239 citations86 referencesContributes 0.027
Kataegis associated mutational processes linked to adverse prostate cancer presentation in African men
Research Square20242 citations45 referencesContributes 0.024
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
American Society of Clinical Oncology Educational Book202315 citations129 referencesContributes 0.021
Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic
Cancers20213 citations67 referencesContributes 0.021
Genetic alterations in CREBRF influence prostate cancer survival and impact prostate tissue homeostasis in mice.
PubMed20231 citations54 referencesContributes 0.013

Authors (32)

Sara Balch,Lauren Sterlin,Beena Thomas ORCID,Sabrina Y. Camp ORCID,Michael Dunphy

Live enrichment

PubMed:36177448 PMC:PMC9518748 OpenAlex:https://openalex.org/W4295988800

National Science Foundation

Grant: GRFP DGE1144152

National Institutes of Health

Grant: R01CA227388

National Institutes of Health

Grant: T32 GM008313

National Institutes of Health

Grant: U01CA233100

U.S. Department of Defense

Grant: PC200150

U.S. Department of Defense

Grant: W81XWH-21-1-0084

NCI NIH HHS

Grant: U2C CA252974

National Institutes of Health

Grant: 5R01CA227388-03

Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors

National Science Foundation

Grant: 1144152

Graduate Research Fellowship Program (GRFP)

National Institutes of Health

Grant: 5T32GM008313-29

Molecular Biophysics Training Grant

National Institutes of Health

Grant: 1U01CA233100-01

Molecular and immune drivers of immunotherapy responsiveness in prostate cancer

National Institutes of Health

Grant: 5U2CCA252974-03

Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults

Puma Biotechnology

Conquer Cancer Foundation

Prostate Cancer Foundation

Roche

Genentech

Broad Institute

American Society of Clinical Oncology

FWCI

0.97

Citation Percentile

0.8%

Citation Trend

2021

2023

2024

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2666979X22001112/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2666979X22001112/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666979X22001112?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666979X22001112?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xgen.2022.100169

Fields of Study

Prostate Cancer Treatment and ResearchCancer Genomics and DiagnosticsProstate Cancer Diagnosis and Treatment0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

General partnershipProstate cancerEconomic shortageMedicineLung cancerExome sequencingExomeOncologyInternal medicineCancerBiologyPolitical scienceGeneArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals